Table 3.
Supportive care use |
nab-Paclitaxel plus carboplatin (n = 61) |
Gemcitabine plus carboplatin (n = 132) |
P-valuea |
---|---|---|---|
Received supportive care, % | 87 | 87 | 0.43 |
Received growth factor (ESA or G-CSF), % | 57 | 46 | 0.15 |
Individual agents (doses/patient/100 days) | |||
ESA agents | 0.7 | 0.7 | 0.86 |
G-CSF agents | 1.6 | 1.4 | 0.58 |
Antiemetics | 9.9 | 9.0 | 0.26 |
Steroids | 10.2 | 9.2 | 0.16 |
Note:
P-value for categorical variables was calculated by χ2; P-value for continuous variables was calculated by independent samples t-test.
Abbreviation: ESA, erythropoiesis-stimulating agent.